EMPIRICAL AND TARGETED TREATMENT FOR TAENIA SOLIUM SOLITARIA (PERU)
Not Applicable
- Conditions
- -B680 Taenia solium taeniasisTaenia solium taeniasisB680
- Registration Number
- PER-082-13
- Lead Sponsor
- IVERSIDAD PERUANA CAYETANO HEREDIA,
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Sex
- Not specified
- Target Recruitment
- 1906
Inclusion Criteria
All community residents older than 2 years of age or weighing more than 11 kg.
Exclusion Criteria
Inability to provide informed consent.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie Taenia solium taeniasis treatment in PER-082-13?
How does empirical treatment compare to targeted therapies for B680 Taenia solium infections?
Are there specific biomarkers for patient stratification in Taenia solium clinical trials?
What adverse events are associated with Taenia solium treatment protocols in Peru?
What drug combinations show promise against Taenia solium compared to standard approaches?